Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2001-9-10
pubmed:abstractText
We studied phospholipid composition of high-density lipoproteins in patients with normo- and hypertriglyceridemia treated with various hypolipidemic preparations (simvastatin and fenofibrate). Both preparations changed phospholipid composition of high-density lipoproteins and improved their functional activity. The differences in the phospholipid composition of high-density lipoproteins were probably related to lipolysis of triglyceride-rich lipoproteins catalyzed by lipoprotein lipase and, in particular, hepatic lipase.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cardiolipins, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Fenofibrate, http://linkedlifedata.com/resource/pubmed/chemical/HDL-triglyceride, http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Lysophosphatidylcholines, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylcholines, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylethanolamines, http://linkedlifedata.com/resource/pubmed/chemical/Phospholipids, http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin, http://linkedlifedata.com/resource/pubmed/chemical/Sphingomyelins, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/high density lipoprotein...
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0007-4888
pubmed:author
pubmed:issnType
Print
pubmed:volume
131
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
321-4
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:11550015-Adult, pubmed-meshheading:11550015-Anticholesteremic Agents, pubmed-meshheading:11550015-Cardiolipins, pubmed-meshheading:11550015-Cholesterol, pubmed-meshheading:11550015-Cholesterol, HDL, pubmed-meshheading:11550015-Fenofibrate, pubmed-meshheading:11550015-Humans, pubmed-meshheading:11550015-Hyperlipidemias, pubmed-meshheading:11550015-Hypolipidemic Agents, pubmed-meshheading:11550015-Lipolysis, pubmed-meshheading:11550015-Lipoproteins, HDL, pubmed-meshheading:11550015-Lysophosphatidylcholines, pubmed-meshheading:11550015-Male, pubmed-meshheading:11550015-Middle Aged, pubmed-meshheading:11550015-Phosphatidylcholines, pubmed-meshheading:11550015-Phosphatidylethanolamines, pubmed-meshheading:11550015-Phospholipids, pubmed-meshheading:11550015-Simvastatin, pubmed-meshheading:11550015-Sphingomyelins, pubmed-meshheading:11550015-Triglycerides
pubmed:year
2001
pubmed:articleTitle
Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemia.
pubmed:affiliation
Department of Metabolic Disorders, State Research Center of Preventive Medicine, Russian Ministry of Health, Moscow.
pubmed:publicationType
Journal Article